Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 3Other solid neoplasm 1Head & Neck 1

Conditions

Head and Neck Neoplasms 2604Squamous Cell Carcinoma of Head and Neck 1880Thyroid Neoplasms 705Nasopharyngeal Carcinoma 627Carcinoma, Non-Small-Cell Lung 478Mouth Neoplasms 424Breast Neoplasms 383Neoplasms 381Oropharyngeal Neoplasms 359Melanoma 339Lung Neoplasms 319Colorectal Neoplasms 307Carcinoma, Squamous Cell 283Neoplasm Metastasis 255Ovarian Neoplasms 254Laryngeal Neoplasms 253Salivary Gland Neoplasms 236Uterine Cervical Neoplasms 234Stomach Neoplasms 223Esophageal Neoplasms 222Nasopharyngeal Neoplasms 221Pancreatic Neoplasms 213Prostatic Neoplasms 203Carcinoma, Renal Cell 201Thyroid Nodule 179Thyroid Cancer, Papillary 178Urinary Bladder Neoplasms 163Sarcoma 160Recurrence 143Hypopharyngeal Neoplasms 143

Interventions

Nivolumab 1Immunotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cutaneous Squamous Cell Carcinoma (CSCC) × Head & Neck × Clear all
NCT06823479 2025-05-29

MATISSE 2

The Netherlands Cancer Institute

Phase 2 Recruiting
41 enrolled
DermatologicHead & Neck

Cutaneous Squamous Cell Carcinoma (CSCC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡